pCDNA3-PAX3-FOXO1/FKHR Citations (1)

Originally described in: The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain.
Lam PY, Sublett JE, Hollenbach AD, Roussel MF Mol Cell Biol. 1999 Jan;19(1):594-601. PubMed

---

Articles Citing pCDNA3-PAX3-FOXO1/FKHR

Articles
PAX3-FOXO1 Drives Targetable Cell State-Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma. Paras KI, Brunner JS, Montero AM, Boyer JA, Jackson BT, Chakraborty S, Xie A, Guillan K, Siddiquee A, Pajuelo Torres L, Rabinowitz JD, Kung AL, You D, Dela Cruz FS, Finley LWS. Cancer Res. 2025 Dec 1;85(23):4718-4733. doi: 10.1158/0008-5472.CAN-25-0315. PubMed

If you have published an article using this material, please email us at to have your article added to this page.